GRI Bio, Inc. (GRI)
NASDAQ: GRI · Real-Time Price · USD
1.680
+0.010 (0.60%)
Nov 5, 2025, 4:00 PM EST - Market closed

GRI Bio Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Nov '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
472---
Market Cap Growth
9.35%325.43%----
Enterprise Value
-13-2---
Last Close Price
1.6814.08595.52---
PB Ratio
1.261.846.72---
P/TBV Ratio
1.271.846.72---
Debt / Equity Ratio
0.030.030.05-0.41-0.74-0.62
Quick Ratio
2.223.070.670.010.020.07
Current Ratio
2.423.431.090.160.020.07
Return on Equity (ROE)
-248.92%-382.52%----
Return on Assets (ROA)
-98.68%-118.39%-416.93%-465.68%-226.54%-
Return on Capital (ROIC)
-151.47%-232.68%----
Earnings Yield
-282.06%-110.90%-749.46%---
FCF Yield
-216.98%-116.36%-517.27%---
Buyback Yield / Dilution
-5323.57%----2.26%-
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q